December 2020

Reimagining Cancer Care Delivery—and Serving Employers—Through Access Hope

December 18, 2020


In an interview with Evidence-Based Oncology™, City of Hope's Harlan Levine discussed the rising interest of employers in cancer care and how AccessHope can help them deliver better care where their employees live.

Pursuing a Different Triple Aim: Employers Seek Better Health Care, Improved Productivity, and Lower Costs

December 17, 2020


In this issue of Evidence-Based Oncology™, we explore the role of collaboration between employers and providers in reducing health care costs, improving workforce health and productivity, and improving health care.

How Halting Telehealth Waivers May Impact Cost, Deferral in Care

November 15, 2020

As some private health insurance companies move to end waivers of cost sharing for virtual care, there will be several aspects to monitor for employers, particularly its impact on accessibility and potential deferral of health care services.

Moving Beyond Precision Oncology to “Precision Prevention” in Oncology Practices

November 11, 2020

In a pair of sessions at the Quality Cancer Care Alliance Virtual Fall Leadership Summit, speakers discussed the promise of precision medicine for not only informing individuals’ cancer treatment decisions but also identifying individuals at high risk before disease develops.

Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge

October 28, 2020

During a session on day 1 of the Community Oncology Alliance (COA) Virtual Payer Exchange Summit on Oncology Payment Reform, a panel of experts discussed the ways COVID-19 continues to impact cancer care and payment reform.

Pembrolizumab Expanded to Treat Relapsed, Refractory cHL in Adults, Children

October 17, 2020


It is the first PD-1 inhibitor to be approved to be used as a monotherapy for the treatment of adult and pediatric patients with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL).

Hodgkin Lymphoma Patients Face Noncancer Death Risk Despite Modern Therapies

October 16, 2020


A study and accompanying editorial from the Journal of Clinical Oncology found that Hodgkin lymphoma survivors still face a higher risk of non-cancer death than the general population.

Analysis Finds Deferral in Care May Fuel Higher Employer Health Care Cost in 2021

October 12, 2020

As the pandemic contributed to a significant decrease in the use of health care services in 2020, an analysis finds that employer health care benefit costs will likely increase in 2021 to address this deferral in care.

Mortality Higher Among Women With Interval vs Screening-Detected Breast Cancers

October 01, 2020


Results from a study on Canadian women who did and did not participate in a population-based breast cancer screening program show that interval breast cancers are more aggressive and deadlier than screening-detected cancers.